167 related articles for article (PubMed ID: 31797692)
61. Enhanced Clearing of Wound-Related Pathogenic Bacterial Biofilms Using Protease-Functionalized Antibiotic Nanocarriers.
Weldrick PJ; Hardman MJ; Paunov VN
ACS Appl Mater Interfaces; 2019 Nov; 11(47):43902-43919. PubMed ID: 31718141
[TBL] [Abstract][Full Text] [Related]
62. A Combination Antibiogram Evaluation for
Puzniak L; DePestel DD; Srinivasan A; Ye G; Murray J; Merchant S; DeRyke CA; Gupta V
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30917987
[No Abstract] [Full Text] [Related]
63. Bacterial biofilm destruction by size/surface charge-adaptive micelles.
Chen M; Wei J; Xie S; Tao X; Zhang Z; Ran P; Li X
Nanoscale; 2019 Jan; 11(3):1410-1422. PubMed ID: 30608101
[TBL] [Abstract][Full Text] [Related]
64. The use of piperacillin-tazobactam coated tympanostomy tubes against ciprofloxacin-resistant Pseudomonas biofilm formation: an in vitro study.
Jang CH; Park H; Cho YB; Choi CH; Park IY
Int J Pediatr Otorhinolaryngol; 2009 Feb; 73(2):295-9. PubMed ID: 19095310
[TBL] [Abstract][Full Text] [Related]
65. PEG-Detachable Polymeric Micelles Self-Assembled from Amphiphilic Copolymers for Tumor-Acidity-Triggered Drug Delivery and Controlled Release.
Xu M; Zhang CY; Wu J; Zhou H; Bai R; Shen Z; Deng F; Liu Y; Liu J
ACS Appl Mater Interfaces; 2019 Feb; 11(6):5701-5713. PubMed ID: 30644711
[TBL] [Abstract][Full Text] [Related]
66. Pharmacodynamic profiling of continuously infused piperacillin/tazobactam against Pseudomonas aeruginosa using Monte Carlo analysis.
Kuti JL; Nightingale CH; Quintiliani R; Nicolau D
Diagn Microbiol Infect Dis; 2002 Sep; 44(1):51-7. PubMed ID: 12376031
[TBL] [Abstract][Full Text] [Related]
67. Synthesis and evaluation of a paclitaxel-binding polymeric micelle for efficient breast cancer therapy.
Xiang J; Wu B; Zhou Z; Hu S; Piao Y; Zhou Q; Wang G; Tang J; Liu X; Shen Y
Sci China Life Sci; 2018 Apr; 61(4):436-447. PubMed ID: 29572777
[TBL] [Abstract][Full Text] [Related]
68. Evaluation of studies on extended versus standard infusion of beta-lactam antibiotics.
Chen M; Buurma V; Shah M; Fahim G
Am J Health Syst Pharm; 2019 Sep; 76(18):1383-1394. PubMed ID: 31505562
[TBL] [Abstract][Full Text] [Related]
69. Activity of Ceftolozane-Tazobactam against Carbapenem-Resistant, Non-Carbapenemase-Producing Pseudomonas aeruginosa and Associated Resistance Mechanisms.
Wi YM; Greenwood-Quaintance KE; Schuetz AN; Ko KS; Peck KR; Song JH; Patel R
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29133568
[TBL] [Abstract][Full Text] [Related]
70. Adriamycin release from poly(lactide-coglycolide)-polyethylene glycol nanoparticles: synthesis, and in vitro characterization.
Davaran S; Rashidi MR; Pourabbas B; Dadashzadeh M; Haghshenas NM
Int J Nanomedicine; 2006; 1(4):535-9. PubMed ID: 17722284
[TBL] [Abstract][Full Text] [Related]
71. Evaluating the anti-biofilm and antibacterial effects of Juglans regia L. extracts against clinical isolates of Pseudomonas aeruginosa.
Dolatabadi S; Moghadam HN; Mahdavi-Ourtakand M
Microb Pathog; 2018 May; 118():285-289. PubMed ID: 29605650
[TBL] [Abstract][Full Text] [Related]
72. In vitro activity of ceftolozane/tazobactam against clinical isolates of Pseudomonas aeruginosa and Enterobacteriaceae recovered in Spanish medical centres: Results of the CENIT study.
Tato M; García-Castillo M; Bofarull AM; Cantón R;
Int J Antimicrob Agents; 2015 Nov; 46(5):502-10. PubMed ID: 26315199
[TBL] [Abstract][Full Text] [Related]
73. Antimicrobial Activity of Ceftolozane-Tazobactam Tested Against Enterobacteriaceae and Pseudomonas aeruginosa with Various Resistance Patterns Isolated in U.S. Hospitals (2013-2016) as Part of the Surveillance Program: Program to Assess Ceftolozane-Tazobactam Susceptibility.
Shortridge D; Pfaller MA; Castanheira M; Flamm RK
Microb Drug Resist; 2018 Jun; 24(5):563-577. PubMed ID: 29039729
[TBL] [Abstract][Full Text] [Related]
74. Activity of ceftolozane/tazobactam against a collection of Pseudomonas aeruginosa isolates from bloodstream infections in Australia.
Henderson A; Tan E; McCarthy KL; Paterson DL
Pathology; 2018 Dec; 50(7):748-752. PubMed ID: 30392710
[TBL] [Abstract][Full Text] [Related]
75. Ocular Permeation of Topical Tazocin and Its Effectiveness in the Treatment of Pseudomonas aeruginosa Induced Keratitis in Rabbits.
Singh S; Agarwal R; Razak ZA; Ngu R; Nyein LL; Vasudevan S; Kapitonova M; Kadir AJ; Visvaraja S
J Ocul Pharmacol Ther; 2018; 34(1-2):214-223. PubMed ID: 29341837
[TBL] [Abstract][Full Text] [Related]
76. In vitro efficacy of colistin against multi-drug resistant Pseudomonas aeruginosa by minimum inhibitory concentration.
Gill MM; Rao JU; Kaleem F; Hassan A; Khalid A; Anjum R
Pak J Pharm Sci; 2013 Jan; 26(1):7-10. PubMed ID: 23261721
[TBL] [Abstract][Full Text] [Related]
77. Urinary piperacillin/tazobactam pharmacokinetics in vitro to determine the pharmacodynamic breakpoint for resistant Enterobacteriaceae.
Gould M; Ginn AN; Marriott D; Norris R; Sandaradura I
Int J Antimicrob Agents; 2019 Aug; 54(2):240-244. PubMed ID: 31108222
[TBL] [Abstract][Full Text] [Related]
78. Release of adriamycin from poly(lactide-co-glycolide)-polyethylene glycol nanoparticles.
Mo SM; Oh IJ
J Nanosci Nanotechnol; 2011 Feb; 11(2):1795-8. PubMed ID: 21456294
[TBL] [Abstract][Full Text] [Related]
79. Synthesis of a novel PEG-block-poly(aspartic acid-stat-phenylalanine) copolymer shows potential for formation of a micellar drug carrier.
Prompruk K; Govender T; Zhang S; Xiong CD; Stolnik S
Int J Pharm; 2005 Jun; 297(1-2):242-53. PubMed ID: 15907607
[TBL] [Abstract][Full Text] [Related]
80. Folate-conjugated amphiphilic star-shaped block copolymers as targeted nanocarriers.
Zhu J; Zhou Z; Yang C; Kong D; Wan Y; Wang Z
J Biomed Mater Res A; 2011 Jun; 97(4):498-508. PubMed ID: 21509931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
